Patent Assignment
Reel/Frame 046031/0381
Security Interest
Recorded: 2018-04-27
Pages: 17
Assignor
MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
Executed: 2018-04-26
Assignee
TD BANK, N.A.
1701 ROUTE 70 EAST, CHERRY HILL, NEW JERSEY, 08034
Covered Properties
(94)
Method of Determining Types I, II, III, IV or V or Methicillin-resistant Staphylococcus aureus (MRSA) in a Biological Sample
Recombinant Soluble Truncated Il-23 Receptor (Il-23R) Capable of Inhibiting Il-23R-Mediated Cell Signaling
Increased CIP2A Expression and Bladder Cancer in Humans
Application:
13/670,787 →
Publication:
US 2013/0115599
Quantitation and Profiling of Vaginal Microflora
Method of Receiving and Handling a Plurality of Clinical Samples for Reporting a Sum of Diagnostic Results for Each Sample
Application:
15/380,264 →
Publication:
US 2017/0098061
Single Nucleotide Polymorphisms and Community-Associated Methicillin-Resistant Staphylococcus aureus
Antibiotic Resistance Profile for Neisseria Gonorrhoeae and Use of Same in Diagnosis and Treatment of Gonorrhea
Application:
15/067,700 →
Publication:
US 2017/0260570
Method of Enhancing Mir-185 Expression to Reduce Low Density Lipoprotein/Cholesterol Accumulation in a Cell
Application:
15/646,437 →
Publication:
US 2018/0010127
METHODS AND REAGENTS THAT SPECIFICALLY DETECT, DISTINGUISH AND QUANTIFY IFN-LAMBDA2 mRNA FROM IFN-LAMBDA3 mRNA IN HUMANS
Pme-1 as a Biomarker to Predict and Diagnose an Increased Risk of Endometrial Cancer and Gene Silencing of Pme-1 to Inhibit Epithelial to Mesenchymal Transition
Novel Cell-Based Assay for Determining Mtor Activity
Novel Cell Based Assay
Application:
15/418,006 →
Publication:
US 2018/0217131
Novel Cell Based Assay
Method and kit for the collection and maintenance of the detectability of a plurality of microbiological species in a single gynecological sample
Application:
11/343,858 →
Publication:
US 2006/0246423
Method of receiving and handling a plurality of clinical samples for reporting a sum of diagnostic results for each sample
Application:
11/343,826 →
Publication:
US 2006/0178838
Compositions and methods for detecting human metapneumovirus
Application:
11/713,408 →
Publication:
US 2008/0213749
DETECTION KIT CONTAINING A NOVEL RECOMBINANT 15-kDA POLYPEPTIDE USEFUL FOR DETECTING HUMAN INFECTION WITH BARTONELLA HENSELAE
Application:
14/048,548 →
Publication:
US 2014/0141457
Babesia Microti Genomic Clones Containing Novel Antigens Useful in the Diagnosis of Babesiosis
Application:
13/713,155 →
Publication:
US 2013/0177941
Method of Determining Susceptibility of a Tumor Cell to a Chemotherapeutic Agent: Novel Use of Herpes SImplex Virus
Application:
14/314,095 →
Publication:
US 2014/0308668
SPLICE VARIANTS OF HUMAN IL-23 RECEPTOR (IL-23R) mRNA AND USE OF A DELTA9 ISOFORM IN PREDICTING INFLAMMATORY BOWEL DISEASES
Application:
13/438,464 →
Publication:
US 2012/0244542
SPLICE VARIANTS OF HUMAN IL-23 RECEPTOR (IL-23R) mRNA AND USE OF A DELTA 9 ISOFORM IN PREDICTING INFLAMMATORY BOWEL DISEASES
Application:
13/764,827 →
Publication:
US 2013/0196333
Single nucleotide polymorphisms as genetic markers for childhood leukemia
Application:
12/455,520 →
Publication:
US 2010/0092959
Novel Haplotype Tagging Single Nucleotide Polymorphisms and Use of Same to Predict Childhood Lymphoblastic Leukemia
Application:
14/938,241 →
Publication:
US 2016/0053333
Single Nucleotide Polymorphisms and Use of Same in Predicting Male-Specific Prenatal Loss
Application:
13/764,803 →
Publication:
US 2014/0045710
Therapeutic Application of Isolated Naturally-Occurring Soluble Truncated Forms of Il-23 Receptor
Application:
13/748,066 →
Publication:
US 2013/0183755
SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENT
Application:
14/830,886 →
Publication:
US 2016/0082034
Antibodies Specific to Antigens of Bartonella Henselae and Use of These Antigens in Immunoassays
Compositions and Methods for Detecting Atopobium Vaginae
Compositions and Methods for Detecting Cryptococcus Neoformans
Method for Determining Azole Resistance in Candida Glabrata
Compositions and Methods for Detecting Borrelia Afzelii
Methods and Compositions Related Thereto for Detecting and Identifying Distinct Species of Nucleic Acids from Causative Agents
Antibodies Specific to Antigens of Bartonella Henselae and Use of These Antigens in Immunoassays
Babesia Microti Genomic Clones Containing Novel Antigens Useful in the Diagnosis of Babesios
Splice Variants of Human Il-23 Receptor (Il-23R) Mrna and Use of a Delta 9 Isoform in Predicting Inflammatory Bowel Diseases
Compositions and Methods for Detecting Borrelia Afzelii
Detection of Penicillin Tolerance in Group B Streptococcus: Single Nucleotide Polymorphisms in Penicillin Binding Protein 4
Hemolysin and Its Protein Fragments in Sero-Detection of Anaplasma Phagocytophilum
Novel Recombinant 15-Kda Polypeptide and Use of Same in Detecting Human Infection with Bartonella Henselae
Ex-Vivo Treatment of Peripheral Plasmacytoid Dendritic Cells with Ifn-Lambda
Protein Fragments of VIRB10 and Sero-Detection of Anaplasma Phagocytophium
Recombinant Fragments and Synthetic Peptides of 17-Kda Polypeptide Useful in Detecting Bartonella Henselae
Type Iv Secretion System Proteins in Sero-Detection of Anaplasma Phagocytophium
Type Iv Secretion System Proteins in Sero-Detection of Anaplasma Phagocytophilum
Identification of a Novel Repressor on Ifn-Lambda Promoter and Sirna Against ZEB1 and Blimp-1 to Increase Ifn-Lambda Gene Activity
Ex-Vivo Treatment of Peripheral Blood Leukocytes with Ifn-Lambda
Compositions and Methods for Detecting Cryptococcus Neoformans
Babesia Microti Genomic Clones Containing Novel Antigens Useful in the Diagnosis of Babesiosis
Protein Fragments of VIRB10 and Sero-Detection of Anaplasma Phagocytophilum
Single Nucleotide Polymorphisms and Use of Same Predicting Male- Specific Prenatal Loss
Methods and Compositions for Detecting Serotypes of Chlamydia Trachomatis Capable of Causing Lymphogranuloma Venereum
Splice Variants of Human Il-23 Receptor (Il-23R) Mrna and Use of a DELTA9 Isoform in Predicting Inflammatory Bowel Diseases
Anaplasma Translocated Substrate-1 (Ats-1) and Sero-Detection of Anaplasma Phagocytophilum
Methods and Compositions for Detecting and Identifying Species of Candida
Detection Kit Containing a Novel Recombinant 15-Kda Polypeptide Useful for Detecting Human Infection with Bartonella Henselae
Anti-Sense Oligonucleotides Targeted Against Exon 9 of Il-23R Alpha Gene and Method of Using Same to Induce Exon Skipping and to Treat Inflammatory Bowel Diseases
DEK as a urine based biomarker for bladder cancer
Method of determining types I, II, III, IV or V or methicillin-resistant staphylococcus aureus (MRSA) in a biological sample
Metronidazole Resistance in Trichomonas Vaginalis and Single Nucleotide Polymorphisms
Detection of a Specific Dek Isoform as a Urine-Based Biomarker for Bladder Cancer
Ex-Vivo Treatment of T-Cells with Ifn-Lambda
Method of Determining Susceptibility of a Tumor Cell to a Chemotherapeutic Agent: Novel Use of Herpes Simplex Virus
Novel Repressor on Ifn-Lambda Promoter and Sirna Against ZEB1 and Blimp-1 to Increase Ifn-Lambda Gene Activity
Hemolysin and its Protein Fragments in Sero-Detection of Anaplasma Phagocytophilum
CIP2A as a biomarker in detection of cervical cancer
Methods and compositions related thereto for detecting and identifying distinct species of nucleic acids from causative agents
Novel Repressor on Ifn-Lambda Promoter and Sirna Against ZEB1 and Blimp-1 to Increase Ifn-Lambda Gene Activity
Novel Polypeptides That Bound to Il-23 Receptor and Inhibit Binding of Il-23 and Cell Signaling Thereof
Methods and Compositions for Detecting Serotypes of Chlamydia Trachomatis Capable of Causing Lymphogranuloma Venereum
Detecting Dna Methylation of BCL2, CDKN2A and NID2 Genes to Predict Bladder Cancer in Humans
Anaplasma Translocated Substrate-1 (Ats-1) and Sero-detection of Anaplasma phagocytophilum
SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENT
Oligonucleotides Useful in Methods for Detecting and Characterizing Aspergillus fumigatus
Novel Repressor on Ifn-Lambda Promoter and Sirna Against ZEB1 and Blimp-1 to Increase Ifn-Lambda Gene Activity
Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof
Anti-Sense Oligonucleotides Targeted Against Exon 9 of IL-23R alpha Gene and Method of Using Same to Induce Exon Skipping and to Treat Inflammatory Bowel Diseases
Novel haplotype tagging single nucleotide polymorphisms and use of same to predict childhood lymphoblastic leukemia
A Method of Enhancing Mir-185 Expression to Reduce Low Density Lipoprotein/Cholesterol Accumulation in a Cell
ELISA Detection of Urine DEK to Predict and Diagnose Bladder Cancer in Humans
Methods and Compositions for Detecting and Identifying Species of Candida
Antibiotic resistance profile for Neisseria gonorrhoeae and use of same in diagnosis and treatment of gonorrhea
Integrated Method for Collection and Maintenance of Detectability of a Plurality of Microbiological Agents in a Single Clinical Sample and for Handling a Plurality of Samples for Reporting a Sum of Diagnostic Results for Each Sample
METHODS AND REAGENTS THAT SPECIFICALLY DETECT, DISTINGUISH AND QUANTIFY IFN-LAMBDA2 mRNA FROM IFN-LAMBDA3 mRNA IN HUMANS
Novel Repressor on Ifn-Lambda Promoter and Sirna Against GATA1, EVI1, and Crx to Alter Ifn-Lambda Gene Activity
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
Metronidazole Resistance in Trichomonas Vaginalis and Single Nucleotide Polymorphisms
Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof
Pme-1 as a Biomarker to Predict and Diagnose an Increased Risk of Endometrial Cancer and Gene Silencing of Pme-1 to Inhibit Epithelial to Mesenchymal Transition
Pme-1 as a Biomarker to Predict and Diagnose Endometrial and Breast Cancer and Gene Silencing of Pme-1 to Inhibit Epithelial to Mesenchymal Transition
Single Nucleotide Polymorphisms and Community-Associated Methicillin-Resistant Staphylococcus Aureus
Elisa Detection of Urine Dek to Predict and Diagnose Bladder Cancer in Humans
Novel Repressor on IFN-Lambda Promoter and siRNA Against GATA1, EVI1, and CRX to Alter IFN-Lambda Gene Activity
Anti-Sense Oligonucleotides Targeted Against Exon 9 of Il-23R-Alpha Gene and Method of Using Same to Induce Exon Skipping and to Treat Inflammatory Bowel Diseases
Method of Enhancing Mir-185 Expression to Reduce Low Density Lipoprotein/Cholesterol Accumulation in a Cell
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 30, 2005
From: ADELSON, MARTIN E.; FEOLA, MELANIE; TRAMA, JASON; MORDECHAI, ELI
To: MEDICAL DIAGNOSTIC LABORATORIES LLC
Reel/Frame 017410/0423 →
Assignment of Assignor's Interest
Dec 24, 2008
From: FEOLA, MELANIE; ADELSON, MARTIN; MORDECHAI, ELI; NOVAK, LISA
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 022053/0836 →
Assignment of Assignor's Interest
Jul 31, 2009
From: GYGAX, SCOTT E.; VERMITSKY, JOHN-PAUL; CHADWICK, SEAN G.; SELF, MATTHEW J.
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 023036/0148 →
Assignment of Assignor's Interest
Oct 1, 2009
From: GYGAX, SCOTT E.; PRASAD, ADITYA; ADELSON, MARTIN E.; MORDECHAI, ELI
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 023321/0834 →
Assignment of Assignor's Interest
Nov 18, 2009
From: FEOLA, MELANIE; ADELSON, MARTIN; MORDECHAI, ELI; ENTWISTLE, JOHN
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 023563/0047 →
Assignment of Assignor's Interest
Dec 7, 2012
From: HUANG, LISA P.; TRAMA, JASON
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 029554/0647 →
Assignment of Assignor's Interest
May 15, 2015
From: GYGAX, SCOTT E; OVERMEYER, CHRISTINA LIM; DESALVIA, LISA A; ADELSON, MARTIN E
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 035650/0700 →
Security Interest
Mar 1, 2016
From: MEDICAL DIAGNOTIC LABORATORIES, L.L.C.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037963/0744 →
Assignment of Assignor's Interest
Aug 1, 2016
From: BRAZAITIS, JONATHAN; GALLAGHER, GRANT; YU, RAYMOND
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 039302/0390 →
Release of Security Interest
Jun 12, 2018
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: MEDICAL DIAGNOSTIC LABORATORIES L. L. C.
Reel/Frame 046354/0817 →
Security Interest
Jul 13, 2022
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 060638/0353 →